Cargando…
Ovarian cancer risk in premenopausal and perimenopausal women treated with Tamoxifen: a case–control study
As tamoxifen stimulates ovarian steroidogenesis in premenopausal women, induces ovulation and increases the incidence of benign ovarian cysts, there has been concern that it might also increase ovarian cancer risk in women treated premenopausally. In a national case–control study in Britain, treatme...
Autores principales: | Swerdlow, A J, Jones, M E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360088/ https://www.ncbi.nlm.nih.gov/pubmed/17285129 http://dx.doi.org/10.1038/sj.bjc.6603605 |
Ejemplares similares
-
Physical activity and risk of breast cancer in premenopausal women
por: Colditz, G A, et al.
Publicado: (2003) -
Body fatness and physical activity at young ages and the risk of breast cancer in premenopausal women
por: Magnusson, C M K, et al.
Publicado: (2005) -
Life-course body size and perimenopausal mammographic parenchymal patterns in the MRC 1946 British birth cohort
por: McCormack, V A, et al.
Publicado: (2003) -
Tamoxifen-induced ovarian hyperstimulation during premenopausal hormonal therapy for breast cancer in Japanese women
por: Yamazaki, Rena, et al.
Publicado: (2015) -
Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women
por: Kim, Min-Jeong, et al.
Publicado: (2016)